LBX Pharmacy Chain Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Li Wang
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 0.01% |
| Management average tenure | 2.3yrs |
| Board average tenure | 3.4yrs |
Recent management updates
Recent updates
CEO
Li Wang (42 yo)
no data
Tenure
CN¥2,230,000
Compensation
Ms. Li Wang is President of LBX Pharmacy Chain Joint Stock Company. She was General Manager of the Strategic Investment Center & Executive Director of LBX Pharmacy Chain Joint Stock Company. She has Master...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Vice President | 2.3yrs | CN¥1.31m | 0.0052% CN¥ 602.8k | |
| Vice President | 3.6yrs | CN¥1.16m | 0.0052% CN¥ 602.8k | |
| Vice President | 3.4yrs | CN¥1.28m | 0.0052% CN¥ 602.8k | |
| President | no data | CN¥2.23m | 0.013% CN¥ 1.5m | |
| CFO & Head of Finance | less than a year | no data | no data | |
| Head of Accounting | no data | no data | no data | |
| Board Secretary | no data | CN¥820.00k | 0.0098% CN¥ 1.1m | |
| Vice President | less than a year | no data | no data |
2.3yrs
Average Tenure
42yo
Average Age
Experienced Management: 603883's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | less than a year | no data | no data | |
| Independent Director | 3.9yrs | CN¥100.00k | no data | |
| Chairman | 10.8yrs | CN¥2.16m | 27.9% CN¥ 3.2b | |
| Director | no data | no data | no data | |
| Director | no data | CN¥100.00k | no data | |
| Director | 2.7yrs | no data | no data | |
| Director | no data | no data | 0.00025% CN¥ 28.9k | |
| Employee Supervisor | 3.9yrs | no data | no data | |
| Independent Director | 2.8yrs | CN¥100.00k | no data |
3.4yrs
Average Tenure
56yo
Average Age
Experienced Board: 603883's board of directors are considered experienced (3.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 17:44 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
LBX Pharmacy Chain Joint Stock Company is covered by 20 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yue Gao | Changjiang Securities Co. LTD. |
| Qianyi Li | China International Capital Corporation Limited |
| Bing Zhao | China Renaissance Securities |